The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
May 19th 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Co-Occuring Gestational Diabetes, Hypertension Linked with Doubling of Future Cardiovascular Risk
November 28th 2022An analysis of more than 800k women in Canada provides insight into the apparent increase in risk of incident cardiovascular disease associated with co-occurrence of gestational diabetes and gestational hypertensive disorders in pregnant women.
FDA Warns 7 Companies Over Illegal Claims of Cardiovascular Benefits from Supplements
November 18th 2022Announced in a statement on November 17, the US FDA issued letters to 7 companies related to unsupported claims of supplements being able to cure, treat, mitigate or prevent cardiovascular disease or related conditions, such as atherosclerosis, stroke or heart failure, in violation of the Federal Food, Drug, and Cosmetic Act.
Maternal Hypertension Linked to Increased Risk of Ischemic Heart Disease, Stroke in Offspring
November 16th 2022An analysis of more than 8 million live singleton births in Nordic countries is providing insight into the impact of maternal preeclampsia on risk of ischemic heart disease and stroke in offspring during childhood and young adulthood.
Subcutaneous ICD Could Reduce Lead-Related Complications By More than 90%
November 14th 2022Data from the ATLAS trial indicate use of a subcutaneous ICD was associated with a 92% reduction in lead-related complications compared to TV-ICD without compromising the effectiveness of shocks, but investigators express caution over an increased incidence of inappropriate shocks with the S-ICD.
Cardiology Case Report: Bradycardia, Diaphoresis, & Syncope
November 11th 2022Our latest case report from Brady Pregerson, MD, features a patient in their mid-60s with a history of hypertension and hyperlipidemia who is brought in by medics with severe bradycardia and diaphoresis after a near syncopal episode. Can you determine the correct diagnosis?
The Heart Team at AHA 2022: PROMINENT Results and Triglycerides, with Aruna Pradhan, MD, MPH
November 9th 2022Aruna Pradhan, MD, MPH, joins The Heart Team at AHA 2022 to discuss the design, results, and her interpretation of the PROMINENT trial for practicing clinicians as well as how she interprets use of triglyceride-lowering agents in the wake of PROMINENT and RESPECT-EPA results.
BEST-CLI: Surgery Best for Avoiding Amputation in PAD Patients
November 7th 2022Data from a pair of presentations at AHA 2022 Scientific Sessions provide clinicians with insight into the effects of surgical vs endovascular procedures for improving prognosis and reducing amputation in patients with peripheral artery disease.
Torsemide Provides No Benefit Over Furosemide for Mortality, Hospitalization in Heart Failure
November 5th 2022Results of the TRANSFORM-HF trial presented at AHA 22 indicate there were no significant differences in rate of all-cause mortality or hospitalization with the use of torsemide compared with furosemide in people with heart failure.